Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2026, Vol. 40 ›› Issue (4): 45-51.doi: 10.6040/j.issn.1673-3770.0.2025.087

• Original Article • Previous Articles     Next Articles

Correlation between moderate-to-severe obstructive sleep apnea-hypopnea syndrome with hypertension and cognitive impairment

CHEN Feier, SHAN Yamin, ZHANG Hao   

  1. Department of Otorhinolaryngology & Head and Neck Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
  • Published:2026-07-10

Abstract: Objective To investigate the effects of moderate-to-severe obstructive sleep apnea hypopnea syndrome(OSAHS)with comorbid hypertension on cognitive impairment and explore associated factors. Methods The participants were stratified into three cohorts: moderate-to-severe OSAHS(n=30), moderate-to-severe OSAHS with comorbid hypertension(n=33), and primary hypertension (n=37), with systematic collection of demographic and clinical parameters including apnea hypopnea index(AHI), and lowest oxygen saturation(LSaO2). Cognitive function was assessed using the Montreal Cognitive Assessment(MoCA), and cerebral white matter lesions were evaluated by modified Fazekas grading on magnetic resonance imaging(MRI). Comparative analyses evaluated cognitive impairment and its influencing factors across three groups. Results The OSAHS-with-hypertension group exhibited significantly lower MoCA scores compared to the OSAHS-alone and hypertension-alone groups(P<0.001). Abnormal Fazekas grades were more prevalent in the OSAHS-with-hypertension group(P<0.001). Correlation analysis revealed a strong negative association between MoCA scores and Fazekas grades(P<0.001)and a positive correlation with lowest oxygen saturation(P<0.001). Logistic regression analysis indicated that the OSAHS-with-hypertension group was significantly associated with abnormalities in MoCA scores(OR=13.049, P<0.001)and Fazekas grading(OR=8.311, P=0.003). Conclusion Patients with moderate-to-severe OSAHS and hypertension exhibit an elevated risk of cognitive impairment, for which cerebral white matter lesions serve as a critical underlying pathology.

Key words: Obstructive sleep apnea hypopnea syndrome, Hypertension, Cognitive function, Montreal cognitive assessment, White matter lesions

CLC Number: 

  • R766.7
[1] Zou JJ, Xia YY, Xu HJ, et al. Independent relationships between cardinal features of obstructive sleep apnea and glycometabolism: a cross-sectional study[J]. Metabolism, 2018, 85: 340-347. DOI: 10.1016/j.metabol.2017.11.021
[2] Léger D, Stepnowsky C. The economic and societal burden of excessive daytime sleepiness in patients with obstructive sleep apnea[J]. Sleep Med Rev, 2020, 51: 101275. DOI: 10.1016/j.smrv.2020.101275
[3] Salman LA, Shulman R, Cohen JB. Obstructive sleep apnea, hypertension, and cardiovascular risk: epidemiology, pathophysiology, and management[J]. Curr Cardiol Rep, 2020, 22(2): 6. DOI: 10.1007/s11886-020-1257-y
[4] Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis[J]. Lancet Respir Med, 2019, 7(8): 687-698. DOI: 10.1016/S2213-2600(19)30198-5
[5] Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment[J]. J Am Geriatr Soc, 2005, 53(4): 695-699. DOI: 10.1111/j.1532-5415.2005.53221.x
[6] Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities[J]. Neurology, 1993, 43(9): 1683-1689. DOI: 10.1212/wnl.43.9.1683
[7] 阻塞性睡眠呼吸暂停合并代谢综合征诊疗专家共识组. 阻塞性睡眠呼吸暂停合并代谢综合征诊疗专家共识(2022)[J]. 中华耳鼻咽喉头颈外科杂志, 2023, 58(2): 99-110. DOI: 10.3760/cma.j.cn115330-20220915-00562
[8] 中华医学会呼吸病学分会睡眠呼吸疾病学组. 睡眠呼吸暂停人群高血压患病率的多中心研究[J]. 中华结核和呼吸杂志, 2007, 30(12): 894-897. DOI: 10.3760/j.issn:1001-0939.2007.12.007
[9] Iulita MF, Girouard H. Treating hypertension to prevent cognitive decline and dementia: re-opening the debate[J]. Adv Exp Med Biol, 2017, 956: 447-473. DOI: 10.1007/5584_2016_98
[10] Zhang XP, Zhou HY, Liu HJ, et al. Role of oxidative stress in the occurrence and development of cognitive dysfunction in patients with obstructive sleep apnea syndrome[J]. Mol Neurobiol, 2024, 61(8): 5083-5101. DOI: 10.1007/s12035-023-03899-3
[11] Dewan NA, Nieto FJ, Somers VK. Intermittent hypoxemia and OSA: implications for comorbidities[J]. Chest, 2015, 147(1): 266-274. DOI: 10.1378/chest.14-0500
[12] Williamson JD, Pajewski NM, et al. Effect of intensive vs standard blood pressure control on probable dementia[J]. Jama, 2019, 321(6): 553. DOI: 10.1001/jama.2018.21442
[13] de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: the rotterdam scan study[J]. Ann Neurol, 2000, 47(2): 145-151. DOI: 10.1002/1531-8249(200002)47:2<145:aid-ana3>3.3.co;2-g
[14] Yoon B, Shim YS, Kim YD, et al. Correlation between instrumental activities of daily living and white matter hyperintensities in amnestic mild cognitive impairment: results of a cross-sectional study[J]. Neurol Sci, 2013, 34(5): 715-721. DOI: 10.1007/s10072-012-1120-z
[15] Al-Janabi OM, Bauer CE, Goldstein LB, et al. White matter hyperintensity regression: comparison of brain atrophy and cognitive profiles with progression and stable groups[J]. Brain Sci, 2019, 9(7): 170. DOI: 10.3390/brainsci9070170
[16] Garde E, Mortensen EL, Rostrup E, et al. Decline in intelligence is associated with progression in white matter hyperintensity volume[J]. J Neurol Neurosurg Psychiatry, 2005, 76(9): 1289-1291. DOI: 10.1136/jnnp.2004.055905
[17] Hansen TM, Croosu SS, Kianimehr S, et al. Quantification of white matter hyperintensities in type 1 diabetes and its relation to neuropathy and clinical characteristics[J]. Brain Res, 2025, 1846: 149288. DOI: 10.1016/j.brainres.2024.149288
[18] Bolandzadeh N, Davis JC, Tam R, et al. The association between cognitive function and white matter lesion location in older adults: a systematic review[J]. BMC Neurol, 2012, 12: 126. DOI: 10.1186/1471-2377-12-126
[19] Carneiro-Barrera A, Díaz-Román A, Guillén-Riquelme A, et al. Weight loss and lifestyle interventions for obstructive sleep apnoea in adults: systematic review and meta-analysis[J]. Obes Rev, 2019, 20(5): 750-762. DOI: 10.1111/obr.12824
[20] Lévy P, Kohler M, McNicholas WT, et al. Obstructive sleep apnoea syndrome[J]. Nat Rev Dis Primers, 2015, 1: 15015. DOI: 10.1038/nrdp.2015.15
[21] Park YJ, Lu TC, Jackson T, et al. Distinct systemic impacts of Aβ42 and Tau revealed by whole-organism snRNA-seq[J]. Neuron, 2025, 113(13): 2065-2082.e8. DOI: 10.1016/j.neuron.2025.04.017
[22] Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges[J]. Lancet Neurol, 2010, 9(7): 689-701. DOI: 10.1016/S1474-4422(10)70104-6
[23] Katsi V, Mavroudis A, Liatakis I, et al. Exploring the relationship between hypertension and cerebral microvascular disease[J]. Diseases, 2024, 12(11): 266. DOI: 10.3390/diseases12110266
[24] Carneiro-Barrera A, Amaro-Gahete FJ, Jurado-Fasoli L, et al. Effect of a weight loss and lifestyle intervention on dietary behavior in men with obstructive sleep apnea: the INTERAPNEA trial[J]. Nutrients, 2022, 14(13): 2731. DOI: 10.3390/nu14132731
[25] Georgoulis M, Yiannakouris N, Kechribari I, et al. The effectiveness of a weight-loss Mediterranean diet/lifestyle intervention in the management of obstructive sleep apnea: Results of the “MIMOSA” randomized clinical trial[J]. Clin Nutr, 2021, 40(3): 850-859. DOI: 10.1016/j.clnu.2020.08.037
[26] Gangitano E, Martinez-Sanchez N, Bellini MI, et al. Weight loss and sleep, current evidence in animal models and humans[J]. Nutrients, 2023, 15(15): 3431. DOI: 10.3390/nu15153431
[27] Sánchez-de-la-Torre M, Gracia-Lavedan E, Benitez ID, et al. Adherence to CPAP treatment and the risk of recurrent cardiovascular events: a meta-analysis[J]. JAMA, 2023, 330(13): 1255-1265. DOI: 10.1001/jama.2023.17465
[28] Liguori C, Cremascoli R, Maestri M, et al. Obstructive sleep apnea syndrome and Alzheimer’s disease pathology: may continuous positive airway pressure treatment delay cognitive deterioration?[J]. Sleep Breath, 2021, 25(4): 2135-2139. DOI: 10.1007/s11325-021-02320-4
[29] Castronovo V, Scifo P, Castellano A, et al. White matter integrity in obstructive sleep apnea before and after treatment[J]. Sleep, 2014, 37(9): 1465-1475. DOI: 10.5665/sleep.3994
[30] Rodriguez-Perez AI, Sucunza D, Pedrosa MA, et al. Angiotensin type 1 receptor antagonists protect against alpha-synuclein-induced neuroinflammation and dopaminergic neuron death[J]. Neurotherapeutics, 2018, 15(4): 1063-1081. DOI: 10.1007/s13311-018-0646-z
[31] McCaw ZR, Kim DH, Wei LJ. Analysis of long-term benefits of intensive blood pressure control[J]. JAMA, 2019, 322(2): 169-170. DOI: 10.1001/jama.2019.5840
[1] ZHAO Chunrong, YANG Sen, LI Chunyan, WANG Donghai, YANG Yu, YANG Xiaoying. Effects of continuous positive airway pressure on olfactory and cognitive functions in patients with moderate-to-severe obstructive sleep apnea-hypopnea syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 68-73.
[2] LI Han, QIAO Xiaofeng. Advances in research on olfactory training that improves cognitive function [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 132-138.
[3] WANG Guifang, LI Rengao, MA Qing. Effects of H-UPPP combined with radiofrequency ablation of tongue root with low temperature plasma on oxygen saturation and arterial oxygen partial pressure in patients with OSAHS [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 49-54.
[4] WANG Lei, LI Baowei, WANG Gang, LIU Hongdan, HAN Haolun, ZHANG Xiaoli, WU Wei. A preliminary study on nocturnal alkali reflux in OSAHS patients [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 75-79.
[5] WANG Teng, YU Lin, LI Sui. The correlation between γ-glutamyl transferase and obstructive sleep apnea syndrome-related hypertension [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 80-84.
[6] YUAN Yuqi, CAO Zine, NIU Xiaoxin, XIE Yushan, SU Yonglong, ZHU Simin, ZHANG Yitong, LIU Haiqin, REN Xiaoyong, SHI Yewen. Clinical significance of peripheral blood inflammatory markers in obstructive sleep apnea hypopnea syndrome with hypertension [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 85-92.
[7] XING Liang, YUAN Yuqi, XIE Yushan, SU Yonglong, NIU Xiaoxin, MA Lina, WANG Zitong, LIU Haiqin, SHI Yewen, REN Xiaoyong. Metabolic markers in obstruetive sleep apnea hypopnea syndrome patients with different arousal thresholds [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 106-111.
[8] DING Longqing, LIU Yiming, CHENG Zhuo, SUN Ran, LIANG Hui. Observation on the therapeutic effect of oropharyngeal exercise on adult obstructive sleep apnea hypopnea syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 153-158.
[9] CHEN Shangli, QIN Tao, CHEN Xuan, CHEN Ruojin, TANG Zhi. Association between homocysteine concentration and the MTHFR C677T polymorphism and hypertension in patients with obstructive sleep apnea hypopnea syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(4): 126-133.
[10] WANG Nan, HUANG Jing, PEN Tao, FENG Bo. Current research on the relationship between obstructive sleep apnea hypopnea syndrome and tinnitus [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(2): 122-127.
[11] ZHANG Xiaoxue, WANG Wei, LIU Jie, XU Zhenju, QIAN Yongheng, HAN Min. The bacteriological characteristics and drug sensitivity of the oropharyngeal region in children and adults with OSAHS [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(1): 35-40.
[12] PAN Jianyun, MO KunlanOverview,HU Yuli, LI ChaoyuGuidance. Research progress in internet medical services of CPAP use in patients with obstructive sleep apnea hypopnea syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(6): 117-122.
[13] HAN Yingying,LI Yanzhong. Obstructive sleep apnea hypopnea syndrome and subclinical arteriosclerosis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 126-132.
[14] SHI Xiaoli, MU Hong. Multidisciplinary diagnosis and treatment of a child with severe obstructive sleep apnea syndrome complicated by pulmonary hypertension [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(1): 116-119.
[15] ZHANG Yitong, LIU Haiqin,REN Xiaoyong. Cognitive and behavioral dysfunction related to obstructive sleep apnea in children: current status, problems, and prospects [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(2): 119-124.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] LIN Bin,WANGHui-ge . Functional endoscopic sinus surgery, FESS[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(6): 481 -487 .
[2] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 84 -87 .
[3] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(2): 116 -118 .
[4] ZHOU Zi-ning,JIN Guo-wei . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(5): 462 -465 .
[5] GONG Lei,SUN Jie,XUE Zi-chao,LI Jing-hua,XUE Wei-guo . DNA analysis of the cell cycle in sino-nasal neoplasm[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(3): 193 -195 .
[6] CHEN Wen-wen . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(5): 472 -472 .
[7] ZHOU Bin,LI Bin . Endoscopic sinus surgery for 75 patients with chronic sinusitis and nasal polyps[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 24 -26 .
[8] YANG Changliang,HUANG Zhiwu,YAO Hangqi,ZHU Yong,SNU Yi . Study on auditory brainstem response[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 9 -13 .
[9] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 89 -89 .
[10] LUAN Jiangang,LIANG Chuanyu,WEN Yanjun,LI Jiong . Construction of RNAi expressing plasmid vector of pSIRENshuttle for EGFR gene silencing[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(1): 4 -8 .